CA3044735C - Formations de cannabinoides hydrosolubles comprenant une enzyme - Google Patents

Formations de cannabinoides hydrosolubles comprenant une enzyme Download PDF

Info

Publication number
CA3044735C
CA3044735C CA3044735A CA3044735A CA3044735C CA 3044735 C CA3044735 C CA 3044735C CA 3044735 A CA3044735 A CA 3044735A CA 3044735 A CA3044735 A CA 3044735A CA 3044735 C CA3044735 C CA 3044735C
Authority
CA
Canada
Prior art keywords
formulation
acid
lipase
detergent
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3044735A
Other languages
English (en)
Other versions
CA3044735A1 (fr
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA3044735A priority Critical patent/CA3044735C/fr
Publication of CA3044735A1 publication Critical patent/CA3044735A1/fr
Application granted granted Critical
Publication of CA3044735C publication Critical patent/CA3044735C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Une formulation pour solubiliser un agent pharmaceutique insoluble dans leau est décrite. La formulation comprend : un agent pharmaceutique insoluble dans leau, un détergent, une enzyme qui décompose les lipides, les protéines et/ou les amidons, un agent plastifiant, un agent émulsifiant et un solvant aqueux. Un procédé de fabrication de la formulation est également décrite.
CA3044735A 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme Active CA3044735C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3044735A CA3044735C (fr) 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3044735A CA3044735C (fr) 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme

Publications (2)

Publication Number Publication Date
CA3044735A1 CA3044735A1 (fr) 2019-08-07
CA3044735C true CA3044735C (fr) 2021-01-19

Family

ID=67542473

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3044735A Active CA3044735C (fr) 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme

Country Status (1)

Country Link
CA (1) CA3044735C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114073671B (zh) * 2020-08-14 2022-12-20 中国科学院化学研究所 一种大麻二酚水溶性组合物、制剂及其制备方法和应用
WO2022043422A1 (fr) * 2020-08-26 2022-03-03 K.D. Pharma Bexbach Gmbh Procédé d'extraction et mélange
LU102018B1 (de) * 2020-08-26 2022-02-28 K D Pharma Bexbach Gmbh Extraktionsverfahren und Stoffgemisch
JP2024530946A (ja) 2021-08-04 2024-08-27 デメトラ アグビオ，インコーポレイテッド カンナビノイド誘導体及びその使用

Also Published As

Publication number Publication date
CA3044735A1 (fr) 2019-08-07

Similar Documents

Publication Publication Date Title
US11298336B2 (en) Water soluble formulation
CA3044735C (fr) Formations de cannabinoides hydrosolubles comprenant une enzyme
EP3490539B1 (fr) Nouvelle formulation par voie orale.
CA1273295A (fr) Capsules a macher
US11166912B2 (en) Orally administrable composition
US9744133B2 (en) Enhanced stability of novel liquid compositions
EP2040672B1 (fr) Compositions liquides de phényléphrine à stabilité améliorée
AU2018221739A1 (en) Formulations
EA027150B1 (ru) Пероральная фармацевтическая композиция, ее применение в медицине и способ лечения путем ее введения
EP1558214B1 (fr) Concentre a administration orale de microemulsion de medicament anti-rhume hydrosoluble
HU227452B1 (en) Mucoadhesive pharmaceutical formulation
CA2922959A1 (fr) Composition administrable par voie orale
JP2006515603A (ja) 粉末医薬組成物
CA3087742C (fr) Forme pharmaceutique sur film
WO2016084099A1 (fr) Composition de capsule en gélatine souple d'agents antitussifs
AU2003222437A1 (en) Pharmaceutical formulation in a drug delivery system and process for preparing the same
US20230023342A1 (en) Chewing gum containing synergistic medicinal compounds
MX2007010163A (es) Composicion farmaceutica liquida acuosa estable a temperatura ambiente.
EP0228223A2 (fr) Solution non irritante à base de suprofène
US20220226240A1 (en) Orally administrable composition
US20240156844A1 (en) Orally administrable formulation
EP4279062A1 (fr) Composition liquide et son utilisation, procédé de traitement et kit
WO2005032516A1 (fr) Formulation et procede de fabrication de capsules d'aceclofenac auto-microemulsionne